BRCA1 and invasive breast carcinoma: (2017) reported that AJ women diagnosed with invasive breast cancer, without a BRCA1/2 founder mutation, have a remaining 1% chance of having a non‐founder BRCA1/2 pathogenic mutation; if she is diagnosed before 40 years of age this chance increases to 3% (Walsh et al., 2017).